V81444

DRUG3 trials

Sponsors

Vernalis (R&D) Ltd

Conditions

ADHDParkinson's Disease

Phase 1

A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

CompletedNCT01634568

Vernalis (R&D) LtdParkinson's Disease

Start: 2011-08-31End: 2012-02-29Updated: 2012-07-10

Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)

CompletedNCT02253745

Vernalis (R&D) LtdADHD

Start: 2013-07-31End: 2014-04-30Updated: 2016-06-03

A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease

CompletedNCT02764892

Vernalis (R&D) LtdParkinson's Disease

Start: 2012-08-31End: 2013-03-31Updated: 2016-05-06